BRPI0414573A - 7-amino alquilidenil-quinolonas e naftiridonas heterocìclicas - Google Patents

7-amino alquilidenil-quinolonas e naftiridonas heterocìclicas

Info

Publication number
BRPI0414573A
BRPI0414573A BRPI0414573-9A BRPI0414573A BRPI0414573A BR PI0414573 A BRPI0414573 A BR PI0414573A BR PI0414573 A BRPI0414573 A BR PI0414573A BR PI0414573 A BRPI0414573 A BR PI0414573A
Authority
BR
Brazil
Prior art keywords
quinolones
alkylidenyl
naphthyridones
amino heterocyclic
heterocyclic
Prior art date
Application number
BRPI0414573-9A
Other languages
English (en)
Inventor
Eugene Bowers Grant Iii
Mark Joseph Macielag
Xiaoqing Xu
Steven D Paget
Michele Ann Weidner-Wells
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0414573A publication Critical patent/BRPI0414573A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"7-AMINO ALQUILIDENIL-QUINOLONAS E NAFTIRIDONAS HETEROCìCLICAS". A presente invenção refere-se a compostos tendo uma estrutura de acordo com a Fórmula I em que n, m, z, R, R2, R3, R4, R5, R6, A, E, X, Y a e b são conforme definido acima; ou um isómero ótico, diastereómero ou enantiómero dos mesmos; um sal, hidrato, ou pró-fármaco farmaceuticamente aceitável dos mesmos.
BRPI0414573-9A 2003-09-22 2004-09-09 7-amino alquilidenil-quinolonas e naftiridonas heterocìclicas BRPI0414573A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50492403P 2003-09-22 2003-09-22
PCT/US2004/029523 WO2005033108A1 (en) 2003-09-22 2004-09-09 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

Publications (1)

Publication Number Publication Date
BRPI0414573A true BRPI0414573A (pt) 2006-11-07

Family

ID=34421521

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414573-9A BRPI0414573A (pt) 2003-09-22 2004-09-09 7-amino alquilidenil-quinolonas e naftiridonas heterocìclicas

Country Status (24)

Country Link
US (1) US7179805B2 (pt)
EP (1) EP1675852B1 (pt)
JP (2) JP2007522093A (pt)
KR (1) KR101137311B1 (pt)
CN (1) CN1997642B (pt)
AR (1) AR045805A1 (pt)
AT (1) ATE423117T1 (pt)
AU (1) AU2004278320B2 (pt)
BR (1) BRPI0414573A (pt)
CA (1) CA2539349C (pt)
CY (1) CY1109424T1 (pt)
DE (1) DE602004019555D1 (pt)
DK (1) DK1675852T3 (pt)
ES (1) ES2321722T3 (pt)
IL (1) IL174397A (pt)
MY (1) MY176860A (pt)
NZ (1) NZ545970A (pt)
PL (1) PL1675852T3 (pt)
PT (1) PT1675852E (pt)
RU (1) RU2350615C2 (pt)
SI (1) SI1675852T1 (pt)
TW (1) TWI359150B (pt)
WO (1) WO2005033108A1 (pt)
ZA (1) ZA200603223B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7761139B2 (en) * 2003-01-24 2010-07-20 The General Hospital Corporation System and method for identifying tissue using low-coherence interferometry
US7732612B2 (en) * 2004-09-09 2010-06-08 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
AU2012244358B2 (en) * 2005-03-21 2015-05-28 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
EP2159225A1 (en) * 2005-06-15 2010-03-03 Hetero Drugs Limited Gemifloxacin process and polymorphs
JO2752B1 (en) * 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
CA2618370A1 (en) 2005-08-04 2007-02-15 Sirtris Pharmaceuticals, Inc. Oxazolopyridine derivatives as sirtuin modulators
WO2007028129A1 (en) * 2005-09-02 2007-03-08 Pfizer Inc. Hydroxy substituted 1h-imidazopyridines and methods
AU2006335042A1 (en) * 2005-10-21 2007-07-19 Glaxo Group Limited Compounds
ES2344523T3 (es) 2005-12-22 2010-08-30 Glaxo Group Limited Compuestos heterociclicos, su preparacion y su uso como agentes antibacterianos.
WO2007110836A1 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A hydride reduction process for preparing quinolone intermediates
PT2001862E (pt) * 2006-03-28 2011-07-20 Warner Chilcott Co Llc Sais de malato e polimorfos do ácido (3s,5s)-7-[3- amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro- 8-metoxi-4-oxo-3-quinolinocarboxílico
BRPI0709220A2 (pt) 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
US20080009628A1 (en) * 2006-07-05 2008-01-10 Michael Reuman One-Pot Condensation-Reduction Methods for Preparing Substituted Allylic Alcohols
DK3092901T3 (da) * 2007-10-05 2020-05-18 Senhwa Biosciences Inc Quinolonanaloger og fremgangsmåder relateret dertil
NZ610978A (en) 2009-05-15 2014-11-28 Redx Pharma Ltd Redox drug derivatives
US20110172193A1 (en) * 2010-01-11 2011-07-14 Mark Macielag Pro-drugs of (e)-7-(3-(2-amino-1-fluoroethylidene)piperidin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CN104098588B (zh) * 2013-04-02 2016-05-25 广州白云山医药集团股份有限公司白云山制药总厂 一类三环喹诺酮衍生物及其制备方法和用途
US10787424B2 (en) 2014-05-21 2020-09-29 New York University Oxopiperazine helix mimetics for control of Hypoxia-Inducible gene expression
WO2017087235A1 (en) 2015-11-20 2017-05-26 Senhwa Biosciences, Inc. Combination therapy of tetracyclic quinolone analogs for treating cancer
US9957282B2 (en) 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
CN112334133A (zh) 2018-02-15 2021-02-05 生华生物科技股份有限公司 喹诺酮类似物及其盐、组合物及其使用方法
RU2671573C1 (ru) * 2018-09-03 2018-11-02 Алина Викторовна Шумадалова 2-[6-метил-4-(тиетан-3-илокси)пиримидин-2-илтио]ацетогидразид малеиновой кислоты, проявляющий противомикробную активность

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS605539B2 (ja) * 1980-03-17 1985-02-12 日東紡績株式会社 耐アルカリ性、耐熱性無機質繊維
AU618235B2 (en) * 1986-03-31 1991-12-19 Sankyo Company Limited Quinoline-3-carboxylic acid derivatives, their preparation and use
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA1332605C (en) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Pyridonecarboxylic acids
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
FR2681865B1 (fr) * 1991-10-01 1993-11-19 Bel Laboratoire Roger Nouveaux derives de la benzonaphtyridine-1,8 leur preparation et les compositions qui les contiennent.
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
JPH06263754A (ja) * 1993-03-12 1994-09-20 Hokuriku Seiyaku Co Ltd ７−アミノピロリジニルキノリン−３−カルボン酸誘導体
ZA944369B (en) * 1993-08-27 1995-02-13 Hokuriku Seuyaku Co Ltd 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
KR960704887A (ko) * 1993-10-14 1996-10-09 챨스 엠. 브록 퀴놀리지논형 화합물 (Quinolizinone type compounds)
US5392154A (en) * 1994-03-30 1995-02-21 Bell Communications Research, Inc. Self-regulating multiwavelength optical amplifier module for scalable lightwave communications systems
KR0131999B1 (ko) * 1994-06-16 1998-04-17 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환제를 갖는 신규 퀴놀린 카르복실산 유도체 및 그의 제조방법
WO1996039407A1 (en) * 1995-06-06 1996-12-12 Abbott Laboratories Quinolizinone type compounds
ATE228130T1 (de) * 1996-02-23 2002-12-15 Bayer Ag Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0)-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3- hinolincarbonsäuren und ihre derivate
ATE423776T1 (de) * 1997-09-15 2009-03-15 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
KR100330409B1 (ko) * 1998-07-23 2002-08-27 한국과학기술원 파장분할다중 방식 다중화/역다중화 장치와 이를 이용한 파장분할다중 방식 수동형 광 가입자망
US6964966B2 (en) * 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments

Also Published As

Publication number Publication date
CN1997642B (zh) 2012-06-13
JP5431515B2 (ja) 2014-03-05
DK1675852T3 (da) 2009-05-25
AU2004278320B2 (en) 2010-06-24
TWI359150B (en) 2012-03-01
ATE423117T1 (de) 2009-03-15
RU2006109004A (ru) 2007-09-27
MY176860A (en) 2020-08-24
AU2004278320A1 (en) 2005-04-14
AR045805A1 (es) 2005-11-16
US20050101588A1 (en) 2005-05-12
TW200526654A (en) 2005-08-16
JP2012162529A (ja) 2012-08-30
PT1675852E (pt) 2009-03-25
CN1997642A (zh) 2007-07-11
EP1675852A1 (en) 2006-07-05
NZ545970A (en) 2009-05-31
CY1109424T1 (el) 2014-08-13
DE602004019555D1 (de) 2009-04-02
IL174397A0 (en) 2006-08-01
RU2350615C2 (ru) 2009-03-27
SI1675852T1 (sl) 2009-06-30
WO2005033108A1 (en) 2005-04-14
CA2539349C (en) 2012-06-05
CA2539349A1 (en) 2005-04-14
IL174397A (en) 2014-01-30
JP2007522093A (ja) 2007-08-09
KR20060097119A (ko) 2006-09-13
ES2321722T3 (es) 2009-06-10
PL1675852T3 (pl) 2009-07-31
EP1675852B1 (en) 2009-02-18
KR101137311B1 (ko) 2012-04-23
ZA200603223B (en) 2007-09-26
US7179805B2 (en) 2007-02-20

Similar Documents

Publication Publication Date Title
BRPI0414573A (pt) 7-amino alquilidenil-quinolonas e naftiridonas heterocìclicas
BRPI0412347A (pt) 2-aminofenil-4-fenilpiridinas como inibidores de quinase
EP1724262A4 (en) 1- (2H) -ISOCHINOLONDERIVAT
CY1118723T1 (el) Ενωσεις βενζοθειαζολιου και αζαβενζοθειαζολιου χρησιμες ως αναστολεiς κινασης
BR0312934A (pt) Derivados de 8-hidróxi quinolina
PE20081530A1 (es) Nuevos compuestos 617
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
NO20021358D0 (no) Alkylendiamin-substituerte heterocykler
EA200500017A1 (ru) Новые соединения
WO2004013120A8 (en) Novel benzodioxoles
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
JO2282B1 (en) Oxazole derivatives
ATE360631T1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
TW200510317A (en) Caspase inhibitors and uses thereof
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
DE69838662D1 (de) Morphinanderivate und ihre medizinische Anwendung
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
EA200401455A1 (ru) Производные бензоксазина в качестве модуляторов 5-htи их применение
ATE498600T1 (de) Inden derivate als pharmazeutika
BRPI0609426B8 (pt) naftiridonas e quinolonas de alquilidenil-heterocíclicas de 7-amino
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
MXPA05009523A (es) Derivados de quinolina/benzoxazinona y sus usos.
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
MXPA04000036A (es) Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C07D 471/04 (2006.01), C07D 401/04 (2006.01), C07D

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL